APO Research
Talk to an analyst

APO RESEARCH · REPORT

Latent Tuberculosis Infection (LTBI) Testing

The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.

Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.

Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.

Selected research

Industry Growth & Trends

Global Latent Tuberculosis Infection (LTBI) Testing Industry Growth and Trends Forecast to 2032

27 December 202587 pages

Choose your research edition.

Industry ResearchLatent Tuberculosis Infection (LTBI) Testing Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Latent Tuberculosis Infection (LTBI) Testing Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Latent Tuberculosis Infection (LTBI) Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Latent Tuberculosis Infection (LTBI) Testing Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Latent Tuberculosis Infection (LTBI) Testing Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.

Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.

Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.

Read the full market overview

According to APO Research, the global Latent Tuberculosis Infection (LTBI) Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

This report provides a structured, data-driven view of the global Latent Tuberculosis Infection (LTBI) Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Latent Tuberculosis Infection (LTBI) Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Latent Tuberculosis Infection (LTBI) Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Latent Tuberculosis Infection (LTBI) Testing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Latent Tuberculosis Infection (LTBI) Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Latent Tuberculosis Infection (LTBI) Testing Market by Company

Qiagen

Sanofi

Oxford Immunotec

Thermo Fisher Scientific

Par Sterile

Bio-Rad Laboratories

Latent Tuberculosis Infection (LTBI) Testing Segment by Type

Tuberculin Skin Test (TST)

Interferon Gamma Released Assay (IGRA)

Latent Tuberculosis Infection (LTBI) Testing Segment by Application

Hospitals and Clinics

Diagnostic Laboratories

Others

Latent Tuberculosis Infection (LTBI) Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latent Tuberculosis Infection (LTBI) Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Latent Tuberculosis Infection (LTBI) Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latent Tuberculosis Infection (LTBI) Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Latent Tuberculosis Infection (LTBI) Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2021-2026) Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2027-2032) Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Type (2021-2026) Table 9. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share Forecasted by Type (2027-2032) Table 11. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Application (2021-2026) Table 24. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share Forecasted by Application (2027-2032) Table 26. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Latent Tuberculosis Infection (LTBI) Testing Industry Trends Table 37. Latent Tuberculosis Infection (LTBI) Testing Industry Drivers Table 38. Latent Tuberculosis Infection (LTBI) Testing Industry Opportunities and Challenges Table 39. Latent Tuberculosis Infection (LTBI) Testing Industry Restraints Table 40. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2021-2026) Table 42. Global Latent Tuberculosis Infection (LTBI) Testing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Latent Tuberculosis Infection (LTBI) Testing Key Company Headquarters & Area Served Table 44. Global Latent Tuberculosis Infection (LTBI) Testing Company, Product Type & Application Table 45. Global Latent Tuberculosis Infection (LTBI) Testing Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Latent Tuberculosis Infection (LTBI) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Qiagen Company Information Table 49. Qiagen Business Overview Table 50. Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Portfolio Table 52. Qiagen Recent Development Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Portfolio Table 57. Sanofi Recent Development Table 58. Oxford Immunotec Company Information Table 59. Oxford Immunotec Business Overview Table 60. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Portfolio Table 62. Oxford Immunotec Recent Development Table 63. Thermo Fisher Scientific Company Information Table 64. Thermo Fisher Scientific Business Overview Table 65. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Portfolio Table 67. Thermo Fisher Scientific Recent Development Table 68. Par Sterile Company Information Table 69. Par Sterile Business Overview Table 70. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Portfolio Table 72. Par Sterile Recent Development Table 73. Bio-Rad Laboratories Company Information Table 74. Bio-Rad Laboratories Business Overview Table 75. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Portfolio Table 77. Bio-Rad Laboratories Recent Development Table 78. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021-2026) & (US$ Million) Table 80. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021-2026) Table 81. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. North America Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Country (2027-2032) Table 83. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021-2026) & (US$ Million) Table 85. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021-2026) Table 86. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Country (2027-2032) Table 88. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021-2026) & (US$ Million) Table 90. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021-2026) Table 91. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Country (2027-2032) Table 93. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021-2026) & (US$ Million) Table 95. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021-2026) Table 96. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Country (2027-2032) Table 98. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021-2026) & (US$ Million) Table 100. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021-2026) Table 101. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Country (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Latent Tuberculosis Infection (LTBI) Testing Product Image Figure 3. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (2021-2032) & (US$ Million) Figure 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region: 2025 VS 2032 Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2021-2032) Figure 7. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Tuberculin Skin Test (TST) Image Figure 13. Global Tuberculin Skin Test (TST) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Interferon Gamma Released Assay (IGRA) Image Figure 15. Global Interferon Gamma Released Assay (IGRA) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2025 VS 2032 Figure 18. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Type (2021-2032) Figure 19. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Type (2021-2032) Figure 21. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Type (2021-2032) Figure 23. Hospitals and Clinics Image Figure 24. Global Hospitals and Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Diagnostic Laboratories Image Figure 26. Global Diagnostic Laboratories Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Others Image Figure 28. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2025 VS 2032 Figure 31. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Application (2021-2032) Figure 32. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Application (2021-2032) Figure 34. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Latent Tuberculosis Infection (LTBI) Testing Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021-2032) Figure 41. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021-2032) Figure 44. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021-2032) Figure 47. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021-2032) Figure 50. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Tuberculin Skin Test (TST)
  • Interferon Gamma Released Assay (IGRA)
Applications
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others
Companies covered
  • Qiagen
  • Sanofi
  • Oxford Immunotec
  • Thermo Fisher Scientific
  • Par Sterile
  • Bio-Rad Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2021-2032)
  5. 1.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2021-2026)
  6. 1.4.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2027-2032)
  7. 1.5 Key Regions Latent Tuberculosis Infection (LTBI) Testing Market Size (2021-2032)
  8. 1.5.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (2021-2032)
2 Latent Tuberculosis Infection (LTBI) Testing Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Tuberculin Skin Test (TST)
  3. 2.1.2 Interferon Gamma Released Assay (IGRA)
  4. 2.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
  5. 2.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions
  9. 2.3.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Type (2021-2026)
3 Latent Tuberculosis Infection (LTBI) Testing Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals and Clinics
  3. 3.1.2 Diagnostic Laboratories
  4. 3.1.3 Others
  5. 3.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
  6. 3.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions
  10. 3.3.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Latent Tuberculosis Infection (LTBI) Testing Industry Trends
  2. 4.2 Latent Tuberculosis Infection (LTBI) Testing Industry Drivers
  3. 4.3 Latent Tuberculosis Infection (LTBI) Testing Industry Opportunities and Challenges
  4. 4.4 Latent Tuberculosis Infection (LTBI) Testing Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Latent Tuberculosis Infection (LTBI) Testing Revenue (2021-2026)
  2. 5.2 Global Latent Tuberculosis Infection (LTBI) Testing Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Latent Tuberculosis Infection (LTBI) Testing Key Company Headquarters & Area Served
  4. 5.4 Global Latent Tuberculosis Infection (LTBI) Testing Company, Product Type & Application
  5. 5.5 Global Latent Tuberculosis Infection (LTBI) Testing Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Latent Tuberculosis Infection (LTBI) Testing Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Latent Tuberculosis Infection (LTBI) Testing Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Latent Tuberculosis Infection (LTBI) Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Qiagen
  2. 6.1.1 Qiagen Company Information
  3. 6.1.2 Qiagen Business Overview
  4. 6.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
  6. 6.1.5 Qiagen Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Oxford Immunotec
  14. 6.3.1 Oxford Immunotec Company Information
  15. 6.3.2 Oxford Immunotec Business Overview
  16. 6.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
  18. 6.3.5 Oxford Immunotec Recent Developments
  19. 6.4 Thermo Fisher Scientific
  20. 6.4.1 Thermo Fisher Scientific Company Information
  21. 6.4.2 Thermo Fisher Scientific Business Overview
  22. 6.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
  24. 6.4.5 Thermo Fisher Scientific Recent Developments
  25. 6.5 Par Sterile
  26. 6.5.1 Par Sterile Company Information
  27. 6.5.2 Par Sterile Business Overview
  28. 6.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
  30. 6.5.5 Par Sterile Recent Developments
  31. 6.6 Bio-Rad Laboratories
  32. 6.6.1 Bio-Rad Laboratories Company Information
  33. 6.6.2 Bio-Rad Laboratories Business Overview
  34. 6.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
  36. 6.6.5 Bio-Rad Laboratories Recent Developments
7 North America
  1. 7.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021-2026)
  3. 7.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021-2026)
  3. 8.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021-2026)
  3. 10.3 South America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst